- Report
- May 2025
- 186 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
From €4485EUR$4,900USD£3,761GBP
- Report
- May 2025
- 185 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 194 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 196 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 184 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 181 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 185 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 180 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- February 2025
- 100 Pages
Global
From €5447EUR$5,950USD£4,567GBP
- Report
- May 2025
- 197 Pages
Global
From €3245EUR$3,545USD£2,721GBP
€3606EUR$3,939USD£3,024GBP
- Report
- May 2025
- 564 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 383 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 250 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 250 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 192 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 182 Pages
Global
From €4531EUR$4,950USD£3,800GBP
- Report
- May 2025
- 173 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- May 2025
- 287 Pages
Global
From €5355EUR$5,850USD£4,491GBP
- Report
- April 2025
- 175 Pages
Global
From €4110EUR$4,490USD£3,447GBP

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease.
Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer.
Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more